Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in Î²-hemoglobinopathy patients

$1,716,494OT2FY2020HLNIH

Boston Children'S Hospital, Boston MA

Investigators

Daniel Evan Bauercontact

Linked publications, trials & patents

Paper 36907603 Paper 36592307 Paper 36522432 Paper 35526095 Paper 34628053

Abstract

No abstract provided

View original record on NIH RePORTER →